# Polyhydramnios

> A condition of **excess amniotic fluid volume** (>2000 mL) during pregnancy.

- Diagnosed by:

  - **Amniotic Fluid Index (AFI)** > 24 cm
  - **Single Deepest Pocket** > 8 cm

## Types:

1. **Acute polyhydramnios**

   - Rapid onset (often in 2nd trimester)
   - More symptomatic

2. **Chronic polyhydramnios**

   - Gradual onset
   - Often asymptomatic or mild

## Causes of Polyhydramnios

> MOTHER’S FLUID

1. Multiple pregnancy

   - Especially with **twin-to-twin transfusion syndrome (TTTS)**

2. Obstruction of fetal swallowing

   - e.g., **Esophageal/duodenal atresia**, anencephaly

3. Twin-to-twin transfusion (TTTS)

   - Donor twin oligohydramnios, recipient twin polyhydramnios

4. Hydrops fetalis

   - Immune (Rh isoimmunisation) or non-immune

5. Endocrine (Maternal diabetes)

   - Hyperglycemia → fetal polyuria → ↑ AF volume

6. Renal disorders (fetal)

   - Increased urine output or decreased resorption

7. Skeletal dysplasia

   - Abnormal fetal movement → swallowing impairment

8. Fetal infections (TORCH)

   - e.g., Parvovirus B19, CMV → anemia, hydrops

9. Laryngeal/tracheal obstruction

   - Impairs swallowing

10. Unexplained (Idiopathic)

    - \~60% cases have no identified cause

11. Isoimmunisation (Rh)

    - Fetal anemia → hydrops → polyhydramnios

12. Down syndrome and other aneuploidies

    - Neuromuscular defects → swallowing issues

## Complications of Polyhydramnios

### Maternal Complications:

1. **Preterm labour**

   - Overdistended uterus → irritability

2. **Abdominal discomfort / breathlessness**

   - Due to uterine size and diaphragmatic elevation

3. **Malpresentation**

   - Excess fluid → fetal mobility → breech or transverse lie

4. **Preterm premature rupture of membranes (PPROM)**

   - Increased pressure on membranes

5. **Placental abruption**

   - Sudden decompression after ROM

6. **Postpartum hemorrhage (PPH)**

   - Uterine atony from overstretching

### Fetal Complications:

1. **Congenital anomalies**

   - Especially GI and CNS (e.g., anencephaly, atresias)

2. **Umbilical cord prolapse**

   - When presenting part is unengaged

3. **Fetal distress**

   - Due to cord compression or malpresentation

4. **Intrauterine fetal death (IUFD)**

   - Especially if associated with hydrops or anomalies

5. **Macrosomia** (if maternal diabetes is the cause)

### Postnatal Complications:

1. **Neonatal respiratory distress**

   - From prematurity or aspiration

2. **Feeding difficulties**

   - In cases with GI malformations

## Management

### Goals of Management:

- Identify and treat underlying cause
- Relieve maternal symptoms
- Prevent preterm labour and obstetric complications
- Ensure safe delivery and fetal wellbeing

### I. Classification-Based Approach

#### A. Mild (AFI 25–30 cm):

- Often idiopathic
- Monitor and expectant management

#### B. Moderate (AFI 30–35 cm) or Severe (>35 cm):

- Needs active evaluation and sometimes intervention

### II. Investigations

#### 1. For Diagnosis

- **Ultrasound (USG)**: Confirm AFI / SDP, fetal anomalies, fetal biometry
- **Serial scans**: Monitor fluid trend, fetal growth

#### 2. For Causes

- **Maternal OGTT**: Rule out diabetes
- **TORCH screen**: If infection suspected
- **Fetal echocardiography**: Rule out heart defects
- **Karyotyping / NIPT**: If structural anomalies or soft markers seen
- **Doppler studies**: In TTTS or hydrops

#### 3. For Complications

- **CTG monitoring**: Fetal wellbeing
- **Cervical length scan**: Predict preterm labour

### III. Antenatal Management

#### A. General Measures

1. **Expectant management** (if mild and asymptomatic)
2. **Treat underlying cause**

   - e.g., Diabetes control, TTTS laser therapy

3. **Monitor for complications**

   - CTG, ultrasound, maternal symptoms

#### B. Symptomatic Relief (Severe cases)

1. **Indomethacin (NSAID)**:

   - ↓ fetal urine production by inhibiting prostaglandins
   - Dose: 25–50 mg orally every 6–8 hrs (short-term use)
   - **Use before 32 weeks only**
   - **Monitor for ductus arteriosus constriction & oligohydramnios**

2. **Amnioreduction** (therapeutic amniocentesis):

   - Removes excess amniotic fluid
   - For acute severe polyhydramnios or maternal respiratory distress
   - Risks: PROM, infection, preterm labour

### IV. Intrapartum Management

#### Delivery Planning:

- **Place**: In well-equipped facility with NICU
- **Time**:

  - Term or earlier if complications (e.g. preterm labour, distress)

- **Mode**:

  - Vaginal if no contraindications
  - **Cesarean if malpresentation or fetal compromise**

#### Precautions during labour:

- **Slow controlled rupture of membranes**
  → prevent **cord prolapse** and **abruption**
- **Monitor for PPH** → uterine atony risk
- Prepare uterotonics, active management of 3rd stage

### V. Postpartum Care

- Monitor:

  - **Uterine tone**
  - **Bleeding**
  - **Neonatal evaluation** (congenital anomalies, respiratory status)

### VI. Contraception / Follow-up

- Genetic counseling if anomaly detected
- Early anomaly scan in next pregnancy
- Pre-pregnancy diabetes control if applicable

### Summary Table:

| Severity | Management Approach                                    |
| -------- | ------------------------------------------------------ |
| Mild     | Observation, monitor AFI and fetal wellbeing           |
| Moderate | Investigate cause, consider indomethacin               |
| Severe   | Amnioreduction, indomethacin, inpatient care if needed |
| Labour   | Controlled ARM, monitor for PPH, delivery planning     |
